Senior insider sale
Chief Financial Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$187.5K
12.50K shares
What this filing means
SCOTT KATHLEEN D. plans to sell 12.50K shares of ARS PHARMACEUTICALS, INC. valued at approximately $187.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001950047-25-006173
Officer· Chief Financial Officer
Since Nov 2022
12.50K
Shares to sell
$187.5K
Approx. market value
12.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/21/2025
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2025 | Stock Option Exercise Cash | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.50K
Market value
$187.5K
8/21/2025
Total
Units
12.50K
Value
$187.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2025 | 12.50K | $187.5K | NASDAQ | Planned |
| Total | 12.50K | $187.5K | ||